CSI's Managing Director, Vanessa Dekou PhD, MBA, hosted an inspiring talk at Imperial College London's Entrepreneurship course, sharing the story behind the creation of Clinical Services International. By identifying a clear gap in the clinical supply market, Vanessa built CSI with a vision to deliver smarter, more agile solutions for global clinical trials. The session was highly engaging and extremely well received, sparking curiosity and ambition among the next generation

A Message of Joy and Gratitude From all of us at Clinical Services International (CSI), we wish you a joyful and peaceful holiday season! As we reflect on the past year, we are filled with gratitude for the incredible partnerships, teamwork, and milestones we have achieved together. This season is a time for celebration and appreciation. Special Christmas Video To commemorate this special time, we have created a heartfelt Christmas video. This video highlights the remarkable

On the 12th day of Christmas CSI gave to me… Twelve reasons sponsors trust CSI, all year long! On the 1st day of Christmas CSI gave to me… Direct Manufacturer Access! Receive faster timelines and documentation thanks to CSI’s direct accounts with global pharma leaders. Reach out to CSI for a sourcing consultation, no matter how big or small your request. On the 2nd day of Christmas CSI gave to me… Unmatched sustainability; with an EcoVadis Platinum rating, putting us in th

As we prepare for Q1 2026, sponsors and CROs face a shifting global landscape for clinical trial comparator sourcing that focuses on sustainability, diversity and fair pricing. With our EcoVadis Platinum certification, women-owned business status and full scientific team in place, CSI is well placed to support our partner’s supply chains. 1. Supply-chain volatility is real Clinical supplies are increasingly challenged by geo-political pressures, export controls, and manufactu

By Clinical Services International As a proud Women-Owned Business , Clinical Services International (CSI) is committed to transforming the global clinical supply landscape while championing gender equity and social responsibility. Founded on the principles of scientific excellence, ethical sourcing and diversity, CSI stands at the forefront of pharmaceutical procurement and supply solutions for clinical trials worldwide. Women-owned businesses are vital to the global econo

As part of our ongoing commitment to excellence and continuous improvement, CSI is proud to announce the digitalization of our Quality Management System (QMS) through Simploud, a leading eQMS platform. This transition marks an important milestone in enhancing both our customer and supplier experience, ensuring greater efficiency, transparency and compliance across our global operations. Simploud’s unified platform will streamline key quality processes (including CAPA mana

Join Us in the Fight Against Breast Cancer October is Breast Cancer Awareness Month, and Clinical Services International (CSI) is proudly wearing pink to show our solidarity with this vital cause. Breast cancer affects millions of lives each year. This month serves as a reminder of the importance of awareness, early detection, and support for those impacted by this disease. Pink is not just a colour; it is a symbol of hope and resilience. By wearing pink, we express our suppo

Client Overview A global biopharmaceutical company approached CSI to support a Phase III oncology study requiring Opdivo (nivolumab) as a comparator. The study spanned 4 countries across North America, Europe and Asia-Pacific, with a target enrolment of over 500 patients. The client’s main objective was to ensure timely delivery of branded Opdivo for multiple trial sites while maintaining transparent, full chain of custody and documentation. Challenge There were several key

At CSI, we’ve built our reputation on being a trusted partner in advancing global health. Among our proudest achievements is our role in...

When it comes to sourcing medicines for Acute Myeloid Leukemia (AML), a supply partner with experience is imperative. At CSI, we’ve built...

At CSI, we understand the urgency and precision required in ophthalmology research. Among the most pressing areas is wet age-related macular degeneration (AMD) a leading cause of vision loss worldwide. Clinical studies in this field demand not only specialized medicines, but also a reliable partner who can ensure seamless supply and global reach. With direct access to all major manufacturers, a fully scientific project team, and a proven track record across ophthalmology prog